TickerFacts.

Cresco Labs Inc. (CRLBF): Operating Income

Annual figures by period end, from SEC filings.

-$27.99M
Year ended 2025-12-31
$107.29M2023-12-31: -$87.82M2024-12-31: $107.29M2025-12-31: -$27.99M-$27.99M
2023-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$27.99Mn/m2026-03-06, From 2025-01-01
2024-12-31$107.29Mn/m2026-03-06, From 2024-01-01
2023-12-31-$87.82Mn/a2025-03-14, From 2023-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Cresco Labs Inc. (CRLBF)2025-12-31-$27.99Mn/m
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31-$17.01Mn/m
Tilray Brands, Inc. (TLRY)2026-05-31-$63.03Mn/m
USANA Health Sciences Inc (USNA)2026-01-03$37.43M-43.6%
Trulieve Cannabis Corp. (TRLV)2025-12-31$143.50M+46.8%
Curaleaf Holdings, Inc. (CURLF)2025-12-31$25.45M+2.9%
Jushi Holdings Inc. (JUSH)2025-12-31$4.85M-55.3%
biote Corp. (BTMD)2025-12-31$35.55M+12.5%
Glass House Brands Inc. (GLAS)2025-12-31-$16.53Mn/m

Compare CRLBF, AAWH, TLRY, USNA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗